ORPEXOS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jul 2020)
What this means for you
This application is over — abandoned 20 Jul 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87710373
- Mark type
- Stylized text
- Filed
- 06 Dec 2017
- Published for opposition
- 24 Apr 2018
- Abandoned
- 20 Jul 2020
- Attorney of record
- Thad Chaloemtiarana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating allergies; pharmaceutical preparations for allergy desensitization
- Class 016 — Paper goods and printed matter: Printed matter, namely, promotional and informational materials in the nature of brochures, guidebooks, pamphlets, and newsletters, relating to pharmaceuticals, immunotherapy and the treatment of allergies; printed materials, namely, brochures and pamphlets, in the field of patient support programs
Owner
- Aimmune Therapeutics, Inc., Brisbane, CA, US
- Aimmune Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 20 Jul 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Jul 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Dec 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2019 — SOU EXTENSION 3 GRANTED
- 16 Dec 2019 — SOU EXTENSION 3 FILED
- 16 Dec 2019 — SOU TEAS EXTENSION RECEIVED
- 31 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2019 — SOU EXTENSION 2 GRANTED
- 29 May 2019 — SOU EXTENSION 2 FILED
- 29 May 2019 — SOU TEAS EXTENSION RECEIVED
- 21 Nov 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2018 — SOU EXTENSION 1 GRANTED
- 19 Nov 2018 — SOU EXTENSION 1 FILED
- 19 Nov 2018 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT